<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02443246</url>
  </required_header>
  <id_info>
    <org_study_id>KDBON-302</org_study_id>
    <nct_id>NCT02443246</nct_id>
  </id_info>
  <brief_title>A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency</brief_title>
  <official_title>A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kwang Dong Pharmaceutical co., ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kwang Dong Pharmaceutical co., ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of Vitamin D3 B.O.N. Intramuscular Injection within 12 weeks with
      that of placebo in adults with Vitamin D Deficiency.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Efficacy Endpoints (serum 25(OH)D concentration)</measure>
    <time_frame>12 weeks</time_frame>
    <description>serum 25(OH)D concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Efficacy Endpoints (serum 25(OH)D concentration)</measure>
    <time_frame>24 weeks</time_frame>
    <description>serum 25(OH)D concentration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D deficiency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D deficiency (Low)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU)</intervention_name>
    <arm_group_label>Vitamin D deficiency</arm_group_label>
    <arm_group_label>Vitamin D deficiency (Low)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Vitamin D deficiency</arm_group_label>
    <arm_group_label>Vitamin D deficiency (Low)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with vitamin D deficiency

        Exclusion Criteria:

          -  Subjects who experienced a hypersensitivity to the cholecalciferol

          -  Subjects with renal impairment

          -  Subjects with Hypercalcemia

          -  Subjects with Hypercalciuria

          -  Subjects with clinically doubted calcium stone

          -  Subjects diagnosed with sarcoidosis

          -  Subjected diagnosed with pseudo-hypoparathyroidism

          -  Subjected with malignancy

          -  Subjects with clinically significant cardiovascular or lung impairment Judged by the
             investigator

          -  Subjects with the below laboratory abnormality (Platelet, WBC, Absolute neutrophil
             count, Albumin, AST or ALT)

          -  Subjects who are to take vitamin D supplements during the study period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung-Kil Lim, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Severance Hospital Seoul, Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yun-seok Jeong, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University Hospital, Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Han-seok Choi, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dongguk University Ilsan Hospital, Korea</affiliation>
  </overall_official>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2015</study_first_submitted>
  <study_first_submitted_qc>May 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2015</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

